Though eye drops are a very common liquid medication, accounting for 2.3% of Medicare Part B expenditures or $2.4 billion annually [9], there are other liquid medications whose consumption could also be better monitored through this new sensor system compared to a standard smart pill bottle.” For example, the insulin required to control diabetes is a liquid medication. The gene discussed is INS; the disease is diabetes mellitus.